Role of aprepitant in chemotherapy induced nausea and vomiting
Journal Title: IP Indian Journal of Anatomy and Surgery of Head, Neck and Brain - Year 2016, Vol 2, Issue 2
Abstract
Abstract Background: Nausea and vomiting is the most common adverse effect of most of the chemotherapeutic agents. Large range of antiemetics has been used since ages. Aprepitant is an NK-1 receptor antagonist which blocks the emetic effects of substance P. The present study is to determine the effectiveness of aprepitant in preventing nausea and vomiting in patients receiving chemotherapy when combined with standard regimen. Methods: In this is an institutional based single arm randomized study patients received aprepitant 125 mg per oral, dexamethasone 8mg intravenous, palonosetron 0.25 mg intravenous 30 min before chemotherapy on scheduled D1 followed by aprepitant 80 mg on Day2 and Day3.The primary end point was the proportion of patients with no emetic episodes and no rescue medication [complete response (CR)] during the 24 h after chemotherapy administration (acute period). Results: Out of 83 patients observed males were 49 and females were 34 and with performance status 0, total of 47.56 (68%) achieved complete response in overall period. This includes 62 patients (74%) in acute period and 49 patients (59%) in delayed period. Conclusion: Aprepitant along with palonosetron and dexamethasone effectively and significantly prevents chemotherapy induced nausea and vomiting.
Authors and Affiliations
Seema Devi, Meka Geeta
Keywords
Related Articles
- EP ID EP243048
- DOI -
- Views 124
- Downloads 0
Salvage of free radial artery forearm flap following reconstruction of lower lateral lip: A case report
Abstract The increasing success rate of free flaps along with their reconstructive advantages have got them into regular practice options in Maxillofacial reconstruction. Although associated complications are inevitable...
Penetrating Tracheal injury- A surgical challenge
Abstract Penetrating Neck injury is rare and tracheal rupture is seen only in 14% cases. Tracheal injury can lead to serious consequences due to airway obstruction, bleeding, aspiration and severe sympathetic stimulation...
Delayed Facial Nerve Palsy after tympano-mastoid Surgery
Aim: Data on delayed facial nerve palsy (DFNP) following tymanomastoid surgery are limited. We conducted a retrospective chart review to determine the incidence, possible predisposing factors, treatment, and prognosis of...
A rare presentation of bronchogenic cyst as dysphagia
Single Nose/ Mono nostril/ Heminose
Congenital anomalies of the nose are thought to be relatively rare, affecting approximately 1 in every 20,000 to 40,000 live births.